cloudfront

Report Detail

Pharma & Healthcare Global (United States, European Union and China) Antidiabetic Biguanides Market Research Report 2019-2025

  • RnM3321528
  • |
  • 17 April, 2019
  • |
  • Global
  • |
  • 111 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global (United States, European Union and China) Antidiabetic Biguanides Market Research Report 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Antidiabetic Biguanides Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Metformin IR
      • 1.3.3 Metformin SR
    • 1.4 Market Segment by Application
      • 1.4.1 Global Antidiabetic Biguanides Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Antidiabetic Biguanides Market Size
      • 2.1.1 Global Antidiabetic Biguanides Revenue 2014-2025
      • 2.1.2 Global Antidiabetic Biguanides Sales 2014-2025
    • 2.2 Antidiabetic Biguanides Growth Rate by Regions
      • 2.2.1 Global Antidiabetic Biguanides Sales by Regions 2014-2019
      • 2.2.2 Global Antidiabetic Biguanides Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Antidiabetic Biguanides Sales by Manufacturers
      • 3.1.1 Antidiabetic Biguanides Sales by Manufacturers 2014-2019
      • 3.1.2 Antidiabetic Biguanides Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Antidiabetic Biguanides Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antidiabetic Biguanides Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Antidiabetic Biguanides Market Concentration Ratio (CR5 and HHI)
    • 3.3 Antidiabetic Biguanides Price by Manufacturers
    • 3.4 Key Manufacturers Antidiabetic Biguanides Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Antidiabetic Biguanides Market
    • 3.6 Key Manufacturers Antidiabetic Biguanides Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Metformin IR Sales and Revenue (2014-2019)
      • 4.1.2 Metformin SR Sales and Revenue (2014-2019)
    • 4.2 Global Antidiabetic Biguanides Sales Market Share by Type
    • 4.3 Global Antidiabetic Biguanides Revenue Market Share by Type
    • 4.4 Antidiabetic Biguanides Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Antidiabetic Biguanides Sales by Application

    6 United States

    • 6.1 United States Antidiabetic Biguanides Breakdown Data by Company
    • 6.2 United States Antidiabetic Biguanides Breakdown Data by Type
    • 6.3 United States Antidiabetic Biguanides Breakdown Data by Application

    7 European Union

    • 7.1 European Union Antidiabetic Biguanides Breakdown Data by Company
    • 7.2 European Union Antidiabetic Biguanides Breakdown Data by Type
    • 7.3 European Union Antidiabetic Biguanides Breakdown Data by Application

    8 China

    • 8.1 China Antidiabetic Biguanides Breakdown Data by Company
    • 8.2 China Antidiabetic Biguanides Breakdown Data by Type
    • 8.3 China Antidiabetic Biguanides Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Antidiabetic Biguanides Breakdown Data by Company
    • 9.2 Rest of World Antidiabetic Biguanides Breakdown Data by Type
    • 9.3 Rest of World Antidiabetic Biguanides Breakdown Data by Application
    • 9.4 Rest of World Antidiabetic Biguanides Breakdown Data by Countries
      • 9.4.1 Rest of World Antidiabetic Biguanides Sales by Countries
      • 9.4.2 Rest of World Antidiabetic Biguanides Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.1.4 Antidiabetic Biguanides Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 AstraZeneca
      • 10.2.1 AstraZeneca Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.2.4 Antidiabetic Biguanides Product Introduction
      • 10.2.5 AstraZeneca Recent Development
    • 10.3 GlaxoSmithKline
      • 10.3.1 GlaxoSmithKline Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.3.4 Antidiabetic Biguanides Product Introduction
      • 10.3.5 GlaxoSmithKline Recent Development
    • 10.4 Merck & Co
      • 10.4.1 Merck & Co Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.4.4 Antidiabetic Biguanides Product Introduction
      • 10.4.5 Merck & Co Recent Development
    • 10.5 Eli Lilly
      • 10.5.1 Eli Lilly Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.5.4 Antidiabetic Biguanides Product Introduction
      • 10.5.5 Eli Lilly Recent Development
    • 10.6 Sanofi
      • 10.6.1 Sanofi Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.6.4 Antidiabetic Biguanides Product Introduction
      • 10.6.5 Sanofi Recent Development
    • 10.7 Takeda Pharmaceuticals
      • 10.7.1 Takeda Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.7.4 Antidiabetic Biguanides Product Introduction
      • 10.7.5 Takeda Pharmaceuticals Recent Development
    • 10.8 Novo Nordisk
      • 10.8.1 Novo Nordisk Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.8.4 Antidiabetic Biguanides Product Introduction
      • 10.8.5 Novo Nordisk Recent Development
    • 10.9 Servier Laboratories
      • 10.9.1 Servier Laboratories Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.9.4 Antidiabetic Biguanides Product Introduction
      • 10.9.5 Servier Laboratories Recent Development
    • 10.10 Boehringer Ingelheim
      • 10.10.1 Boehringer Ingelheim Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Antidiabetic Biguanides
      • 10.10.4 Antidiabetic Biguanides Product Introduction
      • 10.10.5 Boehringer Ingelheim Recent Development
    • 10.11 Bristol-Myers Squibb

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Antidiabetic Biguanides Sales Channels
      • 11.2.2 Antidiabetic Biguanides Distributors
    • 11.3 Antidiabetic Biguanides Customers

    12 Market Forecast

    • 12.1 Global Antidiabetic Biguanides Sales and Revenue Forecast 2019-2025
    • 12.2 Global Antidiabetic Biguanides Sales Forecast by Type
    • 12.3 Global Antidiabetic Biguanides Sales Forecast by Application
    • 12.4 Antidiabetic Biguanides Forecast by Regions
      • 12.4.1 Global Antidiabetic Biguanides Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Antidiabetic Biguanides Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Antidiabetic Biguanides is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antidiabetic Biguanides.

      This report studies the global market size of Antidiabetic Biguanides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Antidiabetic Biguanides sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      AstraZeneca
      GlaxoSmithKline
      Merck & Co
      Eli Lilly
      Sanofi
      Takeda Pharmaceuticals
      Novo Nordisk
      Servier Laboratories
      Boehringer Ingelheim
      Bristol-Myers Squibb

      Market Segment by Product Type
      Metformin IR
      Metformin SR

      Market Segment by Application
      Hospitals
      Clinics
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Antidiabetic Biguanides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Antidiabetic Biguanides manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Antidiabetic Biguanides are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Antidiabetic Biguanides . Industry analysis & Market Report on Antidiabetic Biguanides is a syndicated market report, published as Global (United States, European Union and China) Antidiabetic Biguanides Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antidiabetic Biguanides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,202.52
      3,303.78
      4,405.04
      3,018.26
      4,527.38
      6,036.51
      397,339.20
      596,008.80
      794,678.40
      217,507.95
      326,261.93
      435,015.90
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report